330 related articles for article (PubMed ID: 33720009)
1. Genetic association and causal inference converge on hyperglycaemia as a modifiable factor to improve lung function.
Reay WR; El Shair SI; Geaghan MP; Riveros C; Holliday EG; McEvoy MA; Hancock S; Peel R; Scott RJ; Attia JR; Cairns MJ
Elife; 2021 Mar; 10():. PubMed ID: 33720009
[TBL] [Abstract][Full Text] [Related]
2. Advancing the use of genome-wide association studies for drug repurposing.
Reay WR; Cairns MJ
Nat Rev Genet; 2021 Oct; 22(10):658-671. PubMed ID: 34302145
[TBL] [Abstract][Full Text] [Related]
3. Genetic Correlation and Bidirectional Causal Association Between Type 2 Diabetes and Pulmonary Function.
Zhu J; Zhao H; Chen D; Tse LA; Kinra S; Li Y
Front Endocrinol (Lausanne); 2021; 12():777487. PubMed ID: 34899610
[TBL] [Abstract][Full Text] [Related]
4. TWAS pathway method greatly enhances the number of leads for uncovering the molecular underpinnings of psychiatric disorders.
Chatzinakos C; Georgiadis F; Lee D; Cai N; Vladimirov VI; Docherty A; Webb BT; Riley BP; Flint J; Kendler KS; Daskalakis NP; Bacanu SA
Am J Med Genet B Neuropsychiatr Genet; 2020 Dec; 183(8):454-463. PubMed ID: 32954640
[TBL] [Abstract][Full Text] [Related]
5. Active repurposing of drug candidates for melanoma based on GWAS, PheWAS and a wide range of omics data.
Khosravi A; Jayaram B; Goliaei B; Masoudi-Nejad A
Mol Med; 2019 Jun; 25(1):30. PubMed ID: 31221082
[TBL] [Abstract][Full Text] [Related]
6. Genomics of 1 million parent lifespans implicates novel pathways and common diseases and distinguishes survival chances.
Timmers PR; Mounier N; Lall K; Fischer K; Ning Z; Feng X; Bretherick AD; Clark DW; ; Shen X; Esko T; Kutalik Z; Wilson JF; Joshi PK
Elife; 2019 Jan; 8():. PubMed ID: 30642433
[TBL] [Abstract][Full Text] [Related]
7. Leveraging genetic data to investigate molecular targets and drug repurposing candidates for treating alcohol use disorder and hepatotoxicity.
Gray JC; Murphy M; Leggio L
Drug Alcohol Depend; 2020 Sep; 214():108155. PubMed ID: 32652377
[TBL] [Abstract][Full Text] [Related]
8. Transcriptome-Wide Association Supplements Genome-Wide Association in
Kremling KAG; Diepenbrock CH; Gore MA; Buckler ES; Bandillo NB
G3 (Bethesda); 2019 Sep; 9(9):3023-3033. PubMed ID: 31337639
[TBL] [Abstract][Full Text] [Related]
9. Genetically Regulated Gene Expression in the Brain Associated With Chronic Pain: Relationships With Clinical Traits and Potential for Drug Repurposing.
Johnston KJA; Cote AC; Hicks E; Johnson J; Huckins LM
Biol Psychiatry; 2024 Apr; 95(8):745-761. PubMed ID: 37678542
[TBL] [Abstract][Full Text] [Related]
10. A human-based multi-gene signature enables quantitative drug repurposing for metabolic disease.
Timmons JA; Anighoro A; Brogan RJ; Stahl J; Wahlestedt C; Farquhar DG; Taylor-King J; Volmar CH; Kraus WE; Phillips SM
Elife; 2022 Jan; 11():. PubMed ID: 35037854
[TBL] [Abstract][Full Text] [Related]
11. Identification of drug repurposing candidates for the treatment of anxiety: A genetic approach.
Woodward DJ; Thorp JG; Akosile W; Ong JS; Gamazon ER; Derks EM; Gerring ZF
Psychiatry Res; 2023 Aug; 326():115343. PubMed ID: 37473490
[TBL] [Abstract][Full Text] [Related]
12. Genetics-informed precision treatment formulation in schizophrenia and bipolar disorder.
Reay WR; Geaghan MP; Atkins JR; Carr VJ; Green MJ; Cairns MJ
Am J Hum Genet; 2022 Sep; 109(9):1620-1637. PubMed ID: 36055211
[TBL] [Abstract][Full Text] [Related]
13. Precision drug repurposing via convergent eQTL-based molecules and pathway targeting independent disease-associated polymorphisms.
Vitali F; Berghout J; Fan J; Li J; Li Q; Li H; Lussier YA
Pac Symp Biocomput; 2019; 24():308-319. PubMed ID: 30864332
[TBL] [Abstract][Full Text] [Related]
14. Promoting and supporting self-management for adults living in the community with physical chronic illness: A systematic review of the effectiveness and meaningfulness of the patient-practitioner encounter.
Rees S; Williams A
JBI Libr Syst Rev; 2009; 7(13):492-582. PubMed ID: 27819974
[TBL] [Abstract][Full Text] [Related]
15. Leveraging lung tissue transcriptome to uncover candidate causal genes in COPD genetic associations.
Lamontagne M; Bérubé JC; Obeidat M; Cho MH; Hobbs BD; Sakornsakolpat P; de Jong K; Boezen HM; ; Nickle D; Hao K; Timens W; van den Berge M; Joubert P; Laviolette M; Sin DD; Paré PD; Bossé Y
Hum Mol Genet; 2018 May; 27(10):1819-1829. PubMed ID: 29547942
[TBL] [Abstract][Full Text] [Related]
16. How powerful are summary-based methods for identifying expression-trait associations under different genetic architectures?
Veturi Y; Ritchie MD
Pac Symp Biocomput; 2018; 23():228-239. PubMed ID: 29218884
[TBL] [Abstract][Full Text] [Related]
17. Multi-ancestry transcriptome-wide association analyses yield insights into tobacco use biology and drug repurposing.
Chen F; Wang X; Jang SK; Quach BC; Weissenkampen JD; Khunsriraksakul C; Yang L; Sauteraud R; Albert CM; Allred NDD; Arnett DK; Ashley-Koch AE; Barnes KC; Barr RG; Becker DM; Bielak LF; Bis JC; Blangero J; Boorgula MP; Chasman DI; Chavan S; Chen YI; Chuang LM; Correa A; Curran JE; David SP; Fuentes LL; Deka R; Duggirala R; Faul JD; Garrett ME; Gharib SA; Guo X; Hall ME; Hawley NL; He J; Hobbs BD; Hokanson JE; Hsiung CA; Hwang SJ; Hyde TM; Irvin MR; Jaffe AE; Johnson EO; Kaplan R; Kardia SLR; Kaufman JD; Kelly TN; Kleinman JE; Kooperberg C; Lee IT; Levy D; Lutz SM; Manichaikul AW; Martin LW; Marx O; McGarvey ST; Minster RL; Moll M; Moussa KA; Naseri T; North KE; Oelsner EC; Peralta JM; Peyser PA; Psaty BM; Rafaels N; Raffield LM; Reupena MS; Rich SS; Rotter JI; Schwartz DA; Shadyab AH; Sheu WH; Sims M; Smith JA; Sun X; Taylor KD; Telen MJ; Watson H; Weeks DE; Weir DR; Yanek LR; Young KA; Young KL; Zhao W; Hancock DB; Jiang B; Vrieze S; Liu DJ
Nat Genet; 2023 Feb; 55(2):291-300. PubMed ID: 36702996
[TBL] [Abstract][Full Text] [Related]
18. Next-generation drug repurposing using human genetics and network biology.
Nabirotchkin S; Peluffo AE; Rinaudo P; Yu J; Hajj R; Cohen D
Curr Opin Pharmacol; 2020 Apr; 51():78-92. PubMed ID: 31982325
[TBL] [Abstract][Full Text] [Related]
19. Differential associations of depression-related phenotypes with cardiometabolic risks: Polygenic analyses and exploring shared genetic variants and pathways.
Wong BC; Chau CK; Ao FK; Mo CH; Wong SY; Wong YH; So HC
Depress Anxiety; 2019 Apr; 36(4):330-344. PubMed ID: 30521077
[TBL] [Abstract][Full Text] [Related]
20. Influence of tissue context on gene prioritization for predicted transcriptome-wide association studies.
Li B; Veturi Y; Bradford Y; Verma SS; Verma A; Lucas AM; Haas DW; Ritchie MD
Pac Symp Biocomput; 2019; 24():296-307. PubMed ID: 30864331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
